Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development

作者: Lu Wang , Yan Wang , Zhiyu Song , Jiahui Chu , Xianjun Qu

DOI: 10.1089/JIR.2014.0132

关键词: Colorectal cancerCell growthReceptorBiologyInterferon gammaImmunologyAdenocarcinomaCancer researchAdenomatous polyposis coliGene knockdownWnt signaling pathwayCell biologyVirology

摘要: Genetic variations in interferon-gamma (IFN-γ) and its receptor (IFNγR) subunits are closely associated with the risk of colorectal cancer (CRC) survival after diagnosis. However, role loss IFN-γ or IFNγR function pathogenesis CRC remains unclear. Here, we investigated endogenous deficiency adenomatous polyposis coli (Apc)-mediated intestinal tumor by developing a variant Apc(Min/+) mice. The Apc(Min/+)IFN-γ(+/-) mice presented increased number size adenomas, 41.7% these developed adenocarcinoma. Molecular analyses adenomas suggested that heterozygous deletion promoted EGFR/Erk1/2 Wnt/β-catenin signaling. In vitro, administration inhibited Apc-mutated HT-29 colon cell proliferation had no effect on HCT-116 cells express wild-type Apc. Besides, challenged small interfering RNA targeting one IFNγR1. We found knockdown IFNγR1 stimulated colony formation, which was also related to regulation Thus, our results strongly support notion act as rate-limiting factor development CRC, uncovering novel for them biology.

参考文章(44)
Ronald A. Lubet, Gary Kelloff, Ernest T. Hawk, Kendra Tutsch, Carolyn E. Cole, Russell F. Jacoby, Michael A. Newton, Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Research. ,vol. 60, pp. 1864- 1870 ,(2000)
D Schuhmann, P Godoy, C Weiss, A Gerloff, MV Singer, S Dooley, U Böcker, Interfering with interferon-γ signalling in intestinal epithelial cells: selective inhibition of apoptosis-maintained secretion of anti-inflammatory interleukin-18 binding protein Clinical and Experimental Immunology. ,vol. 163, pp. 65- 76 ,(2011) , 10.1111/J.1365-2249.2010.04250.X
Daniel J. Gough, David E. Levy, Ricky W. Johnstone, Christopher J. Clarke, IFNγ signaling—Does it mean JAK–STAT? Cytokine & Growth Factor Reviews. ,vol. 19, pp. 383- 394 ,(2008) , 10.1016/J.CYTOGFR.2008.08.004
JohnA. Thompson, W.Welby Cox, CatherineG. Lindgren, Carolyn Collins, KathrynA. Neraas, EricM. Bonnem, Alexander Fefer, Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects. Cancer Immunology, Immunotherapy. ,vol. 25, pp. 47- 53 ,(1987) , 10.1007/BF00199300
Gray Pearson, Fred Robinson, Tara Beers Gibson, Bing-e Xu, Mahesh Karandikar, Kevin Berman, Melanie H. Cobb, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews. ,vol. 22, pp. 153- 183 ,(2001) , 10.1210/EDRV.22.2.0428
Hisashi Harada, Tadatsugu Taniguchi, Nobuyuki Tanaka, The role of interferon regulatory factors in the interferon system and cell growth control Biochimie. ,vol. 80, pp. 641- 650 ,(1998) , 10.1016/S0300-9084(99)80017-0
Yan Wang, Dongping Liu, Pingping Chen, H. Phillip Koeffler, Xiangjun Tong, Dong Xie, Negative Feedback Regulation of IFN-γ Pathway by IFN Regulatory Factor 2 in Esophageal Cancers Cancer Research. ,vol. 68, pp. 1136- 1143 ,(2008) , 10.1158/0008-5472.CAN-07-5021
Tanya M. Tekautz, Kejin Zhu, Jose Grenet, Deepak Kaushal, Vincent J. Kidd, Jill M. Lahti, Evaluation of IFN-γ effects on apoptosis and gene expression in neuroblastoma—Preclinical studies Biochimica et Biophysica Acta. ,vol. 1763, pp. 1000- 1010 ,(2006) , 10.1016/J.BBAMCR.2006.06.014
W. Digel, G. Zahn, G. Heinzel, F. Porzsolt, Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-γ in cancer patients Cancer Immunology, Immunotherapy. ,vol. 34, pp. 169- 174 ,(1991) , 10.1007/BF01742308
Eun Joo Park, JJung Whan Shin, Yong Soo Seo, Dae Wun Kim, Seo Yoo Hong, Won Il Park, Byung Moon Kang, Gonadotropin-releasing hormone-agonist induces apoptosis of human granulosa-luteal cells via caspase-8, -9 and -3, and poly-(ADP-ribose)-polymerase cleavage. BioScience Trends. ,vol. 5, pp. 120- 128 ,(2011) , 10.5582/BST.2011.V5.3.120